CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity

Blood

Volumn 90, Issue 6, 1997, Pages 2217-2233

  Schmits, Rudolf ^b   Filmus, Jorge ^b   Gerwin, Nicole ^b   Senaldi, Giorgio ^b   Kiefer, Friedemann ^b   Kundig, Thomas ^b   Wakeham, Andrew ^b   Shahinian, Arda ^b   Catzavelos, Charles ^b   Rak, Janusz ^b   Furlonger, Caren ^b   Zakarian, Arsen ^b   Simard, John J L ^b   Ohashi, Pamela S ^b   Paige, Christopher J ^b   Gutierrez Ramos, Jose C ^b   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; CELLULAR DISTRIBUTION; COLONY FORMING UNIT GM; COLONY FORMING UNIT S; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; GENE TARGETING; GRANULOMA; HEMATOPOIETIC STEM CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030796519     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2217     Document Type: Article

References (126)

1. Zoeller M: CD44: Physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 73:425, 1995
2. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoeller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682, 1992
3. Guenthert U, Hofmann M, Rudy W, Reber S, Zoeller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
4. Wheatley SC, Isacke CM, Crossley PH: Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119:295, 1993
5. Sretavan DW, Feng L, Pure E, Reichardt LF: Embryonic neurons of the developing optic chiasm express L1 and CD44, cell surface molecules with opposing effects on retinal axon growth. Neuron 12:957, 1994
6. Fenderson BA, Stamenkovic I, Aruffo A: Localization of hyaluronan in mouse embryos during implantation, gastrulation and organogenesis. Differentiation 54:85, 1993
7. Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 171:477, 1990
8. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC: Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 75:589, 1990
9. Verfaillie CM, Benis A, Iida J, McGlave PB, McCarthy JB: Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84:1802, 1994
10. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ: Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976, 1995
11. Kansas GS, Muirhead MJ, Dailey MO: Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76:2483, 1990
12. Antica M, Wu L, Shortman K, Scollay R: Thymic stem cells in mouse bone marrow. Blood 84:111, 1994
13. Huang H, Auerbach R: Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc Natl Acad Sci USA 90:10110, 1993
14. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993
15. Horst E, Meijer CJ, Radaskiewicz T, van Dongen JJ, Pieters R, Figdor CG, Hooftman A, Pals ST: Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 4:383, 1990
16. Wu L, Kincade PW, Shortman K: The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett 38:69, 1993
17. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
18. Camp RL, Kraus TA, Birkeland ML, Pure E: High levels of CD44 expression distinguish virgin from antigen-primed B cells. J Exp Med 173:763, 1991
19. Jalkanen S, Saari S, Kalimo H, Lammintausta K, Vainio E, Leino R, Duijvestijn AM, Kalimo K: Lymphocyte migration into the skin: The role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J Invest Dermatol 94:786, 1990
20. Salmi M, Jalkanen S: Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am 20:495, 1991
21. Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H, Butcher EC: Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 145:3247, 1990
22. Toyama Sorimachi N, Miyake K, Miyasaka M: Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+, Mg(2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur J Immunol 23:439, 1993
23. Shimizu Y, Van Seventer GA, Siraganian R, Wahl L, Shaw S: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143:2457, 1989
24. Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, Aune TM: Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147:2493, 1991
25. Denning SM, Le PT, Singer KH, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144:7, 1990
26. Galandrini R, Albi N, Tripodi G, Zarcone D, Terenzi A, Moretta A, Grossi CE, Velardi A: Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150:4225, 1993
27. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A: CD44 contributes to T cell activation. J Immunol 143:798, 1989
28. Seth A, Gote L, Nagarkatti M, Nagarkatti PS: T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci USA 88:7877, 1991
29. Galandrini R, Albi N, Vecchiarelli A, Tognellini R, Zarcone D, Grossi CE, Velardi A: Ligation of the lymphocyte homing receptor CD44 triggers T-helper and cytolytic functions of human T cells. Cytotechnology 11:S100, 1993 (suppl 1)
30. Tan PH, Liu Y, Santos EB, Sandmaier BM: Mechanisms of enhancement of natural killer activity by an antibody to CD44: Increase in conjugate formation and release of tumor necrosis factor alpha. Cell Immunol 164:255, 1995
31. Yang H, Binns RM: CD44 is involved in porcine natural cytotoxicity. Cell Immunol 149:227, 1993
32. Galandrini R, De Maria R, Piccoli M, Frati L, Santoni A: CD44 triggering enhances human NK cell cytotoxic functions. J Immunol 153:4399, 1994
33. Tabi Z, Lynch F, Ceredig R, Allan J, Doherty P: Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol 113:268, 1988
34. Budd R, Cerottini J, Horvath C, Bron C, Pedrazzini T, Howe R, MacDonald H: Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 138:3120, 1987
35. Sanders M, Makgoba M, Sharrow S, Stephany D, Springer T, Young H, Shaw S: Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 140:1401, 1988
36. Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C: CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672, 1995
37. Howie SE, Sommerfield AJ, Gray E, Harrison DJ: Peripheral T lymphocyte depletion by apoptosis after CD4 ligation in vivo: Selective loss of CD44-and 'activating' memory T cells. Clin Exp Immunol 95:195, 1994
38. Zhou T, Edwards CK-3rd, Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 182:129, 1995
39. Camp RL, Scheynius A, Johansson C, Pure E: CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178:497, 1993
40. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235, 1993
41. Toelg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225, 1993
42. Brown TA, Bouchard T, St John T, Wayner E, Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207, 1991
43. Green SJ, Tarone G, Underhill CB: Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. Exp Cell Res 178:224, 1988
44. Gallatin WM, Wayner EA, Hoffman PA, St John T, Butcher EC, Carter WG: Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci USA 86:4654, 1989
45. Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Moscarello MA: Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol 50:779, 1991
46. Girgrah N, Ackerley CA, Moscarello MA: Localization of CD44 (P80) on the external surface of a human astrocytoma cell. Neuroreport 2:441, 1991
47. Vogel H, Butcher EC, Picker LJ: H-CAM expression in the human nervous system: Evidence for a role in diverse glial interactions. J Neurocytol 21:363, 1992
48. Asher R, Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203:80, 1992
49. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057, 1989
50. Nottenburg C, Rees G, St John T: Isolation of mouse CD44 cDNA: Structural features are distinct from the primate cDNA. Proc Natl Acad Sci USA 86:8521, 1989
51. Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC: A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1063, 1989
52. Siegelman MH, Weissman IL: Human homologue of mouse lymph node homing receptor: Evolutionary conservation at tandem cell interaction domains. Proc Natl Acad Sci USA 86:5562, 1989
53. Zhou DF, Ding JF, Picker LJ, Bargatze RF, Butcher EC, Goeddel DV: Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol 143:3390, 1989
54. Pure E, Camp RL, Peritt D, Panettieri RA Jr, Lazaar AL, Nayak S: Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181:55, 1995
55. Perschl A, Lesley J, English N, Trowbridge I, Hyman R: Role of CD44 cytolasmic domain in hyaluronan binding. Eur J Immunol 25:495, 1995
56. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673, 1995
57. Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB: Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J Cell Sci 105:501, 1993
58. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687, 1995
59. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB: A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521, 1992
60. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817, 1992
61. Herrlich P, Zoeller M, Pals ST, Ponta H: CD44 splice variants: Metastases meet lymphocytes. Immunol Today 14:395, 1993
62. Guenthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 24:19, 1995
63. Imazeki F, Yokosuka O, Yamaguchi T, Ohto M, Isono K, Omata M: Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology 110:362, 1996
64. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D, Favrot M: Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 14:25, 1996
65. Fung Leung WP, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider M, Potter J, van Ewijk W, Mak TW: CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65:443, 1991
66. Bradley A, Robertson E: Embryo-derived stem cells: A tool for elucidating the developmental genetics of the mouse. Curr Top Dev Biol 20:357, 1986
67. Bradley A, Evans M, Kaufman MH, Robertson E: Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309:255, 1984
68. Roost H, Charan S, Gobet R, Ruedi E, Hengartner H, Althage A, Zinkernagel RM: An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus. Eur J Immunol 18:511, 1988
69. Scott DW, Gershon RK: Determination of total mercaptoethanol-resistant antibody in the same serum sample. Clin Exp Immunol 6:313, 1970
70. Kundig TM, Bachmann MF, DiPaolo C, Simard JJL, Battegay M, Lother H, Gessner A, Kuehlcke K, Ohashi PS, Hengartner H, Zinkernagel RM: Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268:1343, 1995
71. Hawley RG, Lieu FH, Fong AZ, Hawley TS: Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1:136, 1994
72. St John T, Meyer J, Idzerda R, Gallatin WM: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:45, 1990
73. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54:4539, 1994
74. Takahashi K, Stamenkovic I, Cutler M, Saya H, Tanabe KK: CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 11:2223, 1995
75. Patel DD, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF: Expression of CD44 molecules and CD44 ligands during human thymic fetal development: Expression of CD44 isoforms is developmentally regulated. Int Immunol 7:277, 1995
76. Lesley J, Schulte R, Trotter J, Hyman R: Qualitative and quantitative heterogeneity in Pgp-1 expression among murine thymocytes. Cell Immunol 112:40, 1988
77. Godfrey DI, Kennedy J, Suda T, Zlotnik A: A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 150:4244, 1993
78. Andjelic S, Jain N, Nikolic Zugic J: Ontogeny of fetal CD81o41o thymocytes: Expression of CD44, CD25 and early expression of TcR alpha mRNA. Eur J Immunol 23:2109, 1993
79. Aizawa S, Tavassoli M: Molecular basis of the recognition of intravenously transplanted hemopoietic cells by bone marrow. Proc Natl Acad Sci USA 85:3180, 1988
80. Aizawa S, Tavassoli M: In vitro homing of hemopoietic stem cells is mediated by a recognition system with galactosyl and mannosyl specificities. Proc Natl Acad Sci USA 84:4485, 1987
81. Shinde S, Wu Y, Guo Y, Niu Q, Xu J, Grewal IS, Flavell R, Liu Y: CD40L is important for induction of, but not response to, costimulatory activity. J Immunol 157:2764, 1996
82. Heine J, Moon HW, Woodmansee DB: Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immunol 43:856, 1984
83. + T lymphocytes in protective immunity. J Immunol 147:1014, 1991
84. Aizawa S, Tavassoli M: Expression of lectin receptors on the surface of granulocyte-macrophage progenitor cells (CFU-gm). Int J Cell Cloning 4:464, 1986
85. Chong AS, Boussy IA, Graf LH, Scuderi P: Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: Costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Cell Immunol 144:69, 1992
86. Zembala M, Siedlar M, Ruggiero I, Wieckiewicz J, Mytar B, Mattei M, Colizzi V: The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56:269, 1994
87. Noble PW, Lake FR, Henson PM, Riches DW: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91:2368, 1993
88. Gruber MF, Webb DS, Gerrard TL: Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta. J Immunol 148:1113, 1992
89. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361:79, 1993
90. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509, 1996
91. Amakawa R, Hakem A, Kundig T, Matsuyama T, Simard JJL, Timms E, Wakeham A, Mittrucker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger J, Mak TW: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:1, 1996
92. Hale LP, Singer KH, Haynes BF: CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells. J Immunol 143:3944, 1989
93. Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS: Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol 152:186, 1993
94. Sommer F, Huber M, Roellinghoff M, Lohoff M: CD44 plays a co-stimulatory role in murine T cell activation: Ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells. Int Immunol 7:1779, 1995
95. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J: The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257, 1993
96. Xu JC, Grewal IS, Geba GP, Flavell RA: Impaired primary T-cell responses in L-selectin-deficient mice. J Exp Med 183:589, 1996
97. Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJL, Duncan G, Wakeham A, Shahinian A, van der Heiden A, Bachmann MF, Ohashi PS, Mak TW, Hickstein DD: LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med 183:1415, 1996
98. Lee WT, Vitetta ES: The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cell Immunol 132:215, 1991
99. Lesley J, Hyman R: CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719, 1992
100. Lynch F, Ceredig R: Mouse strain variation in Ly-24 (Pgp-1) expression by peripheral T cells and thymocytes: Implications for T cell differentiation. Eur J Immunol 19:223, 1989
101. Lesley J, Trowbridge I: Genetic characterization of a polymorphic murine cell-surface glycoprotein. Immunogenetics 15:313, 1982
102. Dannenberg A Jr: Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 12:228, 1991
103. Falini B, Flenghi L, Pileri S, Pelicci P, Fagioli M, Martelli M, Moretta L, Ciccone E: Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol 143:2480, 1989
104. Kaufmann SH: CD8+ T lymphocytes in intracellular microbial infections. Immunol Today 9:168, 1988
105. Sander B, Skansen-Saphir U, Damm O, Hakansson L, Andersson J, Andersson U: Sequential production of TH1 and TH2 cytokines in response to live bacillus Calmette-Guerin. Immunology 86:512, 1995
106. Huygen K, Abramowicz D, Vandenbussche P, Jacobs F, De Bruyn J, Kentos A, Drowart A, Van Vooren J-P, Goldman M: Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun 60:2880, 1992
107. Harp JA, Whitmire WM, Sacco R: In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryotosporidium parvum antigen. J Parasitol 80:67, 1994
108. Mosmann TR, Sad S: The expanding universe of T-cell subsets: TH2, TH2 and more. Immunol Today 17:138, 1996
109. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival [see comments]. Lancet 345:615, 1995
110. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation [see comments]. Lancet 340:1053, 1992
111. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227, 1993
112. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754, 1993
113. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859, 1991
114. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody [published erratum appears in Cancer Res 54:2284, 1994]. Cancer Res 54:1561, 1994
115. Shtivelman E, Bishop JM: Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11:5446, 1991
116. Benard J: Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma. Eur J Cancer 31:560, 1995
117. Seelentag WK, Guenthert U, Saremaslani P, Futo E, Pfaltz M, Heitz PU, Roth J: CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 69:218, 1996
118. Terpe HJ, Stoerkel S, Zimmer U, Anquez V, Fischer C, Pantel K, Guenthert U: Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 148:453, 1996
119. Terpe HJ, Christiansen H, Gonzalez M, Berthold F, Lampert F: Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 31:549, 1995
120. Friedrichs K, Franke F, Lisboa BW, Kuegler G, Gille I, Terpe HJ, Hoelzel F, Maass H, Guenthert U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55:5424, 1995
121. Webb DS, Shimizu Y, Van Seventer GA, Shaw S, Gerrard TL: LFA-3, CD44 and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295, 1990
122. DeGrendele HC, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothial cell primary adhesion pathway. J Exp Med 183:1119, 1996
123. Brissett NC, Perkins SJ: The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily. FEBS Lett 388:211, 1996
124. Toole BP: Hyaluronan and its binding protein, the hyaladherins. Cur Opin Cell Biol 2:839, 1990
125. Yang B, Yang BL, Savani C, Turley EA: Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13:286, 1994
126. Kohda D, Morton CJ, Parkar AA, Hatanaka H, Inagaki FM, Campbell ID, Day AJ: Solution structure of the link module: A hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86:767, 1996